Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
To access this article, please choose from the options below
PII: S0197-4580(06)00079-0
doi:10.1016/j.neurobiolaging.2006.02.015
© 2006 Elsevier Inc. All rights reserved.
